XML 147 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Instruments (Tables)
12 Months Ended
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments Reported in Financial Position The detail of derivative instruments is shown below (in thousands, except number of instruments):
 
 
 
 
December 31,
Derivatives Not Designated
as Hedging Instruments
 
Location in the Consolidated
Statements of Financial Position
 
2019
 
2018
Number of
Instruments
 
Notional
Amounts
 
Estimated
Fair Value
 
Number of
Instruments
 
Notional
Amounts
 
Estimated
Fair Value
Equity-indexed options
 
Other invested assets
 
473

 
$
2,654,600

 
$
256,005

 
493

 
$
2,391,000

 
$
148,006

Equity-indexed embedded derivative
 
Policyholders’ account balances
 
101,950

 
2,527,205

 
731,552

 
90,440

 
2,327,769

 
596,075


Schedule of Derivative Instruments Reported in Statements of Operations
 
 
 
 
Gains (Losses) Recognized in Income  on Derivatives
Derivatives Not Designated
as Hedging Instruments
 
Location in the Consolidated
Statements of Operations
 
Years ended December 31,
2019
 
2018
 
2017
Equity-indexed options
 
Net investment income
 
$
144,980

 
$
(54,951
)
 
$
91,055

Equity-indexed embedded derivative
 
Interest credited to policyholders’ account balances
 
(162,011
)
 
17,862

 
(98,351
)

Schedule of Information Regarding Company's Exposure to Credit Loss on the Options Holds
Information regarding the Company’s exposure to credit loss on the options it holds is presented below (in thousands):
 
 
 
 
December 31, 2019
Counterparty
 
Moody/S&P
Rating
 
Options Fair
Value
 
Collateral Held in Cash
 
Collateral Held in Invested Assets
 
Total Collateral
Held
 
Collateral
Amounts used to Offset Exposure
 
Excess
Collateral
 
Exposure  Net of Collateral
Barclays
 
Baa3/BBB
 
$
54,583

 
$
27,343

 
$
28,000

 
$
55,343

 
$
54,583

 
$
760

 
$

Credit Suisse
 
Baa2/BBB+
 
7,117

 
7,390

 

 
7,390

 
7,009

 
381

 
108

Goldman-Sachs
 
A3/BBB+
 
1,053

 
930

 

 
930

 
930

 

 
123

ING
 
Baa1/A-
 
30,330

 
14,940

 
16,000

 
30,940

 
30,330

 
610

 

Morgan Stanley
 
A3/BBB+
 
34,988

 
25,926

 
9,000

 
34,926

 
34,926

 

 
62

NATIXIS*
 
A1/A+
 
29,918

 
30,200

 

 
30,200

 
29,918

 
282

 

SunTrust
 
A3/A-
 
60,360

 
41,720

 
17,000

 
58,720

 
58,645

 
75

 
1,715

Wells Fargo
 
A2/A-
 
37,656

 
24,110

 
15,000

 
39,110

 
37,656

 
1,454

 

Total
 
 
 
$
256,005

 
$
172,559

 
$
85,000

 
$
257,559

 
$
253,997

 
$
3,562

 
$
2,008

 
 
 
 
December 31, 2018
Counterparty
 
Moody/S&P
Rating
 
Options Fair
Value
 
Collateral Held in Cash
 
Collateral Held in Invested Assets
 
Total Collateral
Held
 
Collateral
Amounts used to Offset Exposure
 
Excess
Collateral
 
Exposure  Net of Collateral
Barclays
 
Baa3/BBB
 
$
38,905

 
$
11,063

 
$
28,041

 
$
39,104

 
$
38,905

 
$
199

 
$

Goldman-Sachs
 
A3/BBB+
 
615

 
670

 

 
670

 
615

 
55

 

ING
 
Baa1/A-
 
24,183

 
7,960

 
16,023

 
23,983

 
23,983

 

 
200

Morgan Stanley
 
A3/BBB+
 
11,649

 
2,046

 
9,013

 
11,059

 
11,059

 

 
590

NATIXIS*
 
A1/A+
 
26,786

 
27,610

 

 
27,610

 
26,786

 
824

 

SunTrust
 
Baa1/BBB+
 
23,488

 
6,520

 
17,025

 
23,545

 
23,464

 
81

 
24

Wells Fargo
 
A2/A-
 
22,380

 
7,030

 
15,022

 
22,052

 
22,052

 

 
328

Total
 
 
 
$
148,006

 
$
62,899

 
$
85,124

 
$
148,023

 
$
146,864

 
$
1,159

 
$
1,142

*
Includes collateral restrictions